Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer

Nature Communications

Volumn 7, Issue , 2016, Pages

  Du, Zhou ^a,b   Sun, Tong ^c,d,e   Hacisuleyman, Ezgi ^f,g,h   Fei, Teng ^c,d   Wang, Xiaodong ^c,d   Brown, Myles ^c,d   Rinn, John L ^g,h,i   Lee, Mary Gwo Shu ^c,d   Chen, Yiwen ^j   Kantoff, Philip W ^c,d,k   Liu, X Shirley ^c,l  

^a SHANGHAI PULMONARY HOSPITAL   (China)

^b TONGJI UNIVERSITY   (China)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HARVARD UNIVERSITY   (United States)

^g Harvard University   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLYCOMB REPRESSIVE COMPLEX 2; SMALL INTERFERING RNA; PTEN PROTEIN, HUMAN; TUG1 LONG NONCODING RNA, HUMAN;

CANCER; CYTOPLASM; GENE EXPRESSION; PROTEIN; RNA; TUMOR;

3' UNTRANSLATED REGION; ARTICLE; CELL FRACTIONATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; IMMUNOPRECIPITATION; PRIMARY TUMOR; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STOICHIOMETRY; TRANSCRIPTION REGULATION; ADENOCARCINOMA; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; HUMAN; MALE; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; RNA TRANSPORT; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL FRACTIONATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HCT116 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 2; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA TRANSPORT; RNA, LONG NONCODING;

EID: 84961401406     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10982     Document Type: Article

References (45)

1. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789 (2012).
2. Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915-1927 (2011).
3. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
4. Prensner, J. R. and Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391-407 (2011).
5. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
6. Ebert, M. S. and Sharp, P. A. Emerging roles for natural microRNA sponges. Curr. Biol. 20, R858-R861 (2010).
7. Ebert, M. S., Neilson, J. R. and Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726 (2007).
8. Franco-Zorrilla, J. M. et al. Target mimicry provides a new mechanism for regulation of microRNA activity. Nature Genet. 39, 1033-1037 (2007).
9. Salmena, L., Poliseno, L., Tay, Y., Kats, L. and Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358 (2011).
10. Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369 (2011).
11. Cazalla, D., Yario, T. and Steitz, J. A. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328, 1563-1566 (2010).
12. Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038 (2010).
13. Du, Z. et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 20, 908-913 (2013).
14. Sansal, I. and Sellers, W. R. The biology and clinical relevance of the PTEN tumor suppressor pathway. J. Clin. Oncol. 22, 2954-2963 (2004).
15. Maehama, T. and Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998).
16. Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998).
17. Sun, H. et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl Acad. Sci. USA 96, 6199-6204 (1999).
18. Bettendorf, O. et al. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes Chromosomes Cancer 47, 565-572 (2008).
19. Han, B. et al. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression. Mod. Pathol. 22, 1083-1093 (2009).
20. Kronz, J. D., Allan, C. H., Shaikh, A. A. and Epstein, J. I. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am. J. Surg. Pathol. 25, 1079-1085 (2001).
21. Yoshimoto, M. et al. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet. Cytogenet. 169, 128-137 (2006).
22. El Sheikh, S. S., Romanska, H. M., Abel, P., Domin, J. and Lalani, e. l. N. Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer-a pilot study. Neoplasia 10, 949-953 (2008).
23. Reid, A. H. et al. Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br. J. Cancer 102, 678-684 (2010).
24. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22 (2010).
25. Lunardi, A. et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genet. 45, 747-755 (2013).
26. Chaux, A. et al. Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod. Pathol. 25, 1543-1549 (2012).
27. Sumazin, P. et al. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147, 370-381 (2011).
28. Tay, Y. et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357 (2011).
29. Erho, N. et al. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS ONE 8, e66855 (2013).
30. Young, T. L., Matsuda, T. and Cepko, C. L. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr. Biol. 15, 501-512 (2005).
31. Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA 106, 11667-11672 (2009).
32. Yang, L. et al. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147, 773-788 (2011).
33. van Heesch, S. et al. Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes. Genome Biol. 15, R6 (2014).
34. Cummins, J. M. et al. The colorectal microRNAome. Proc. Natl Acad. Sci. USA 103, 3687-3692 (2006).
35. Raj, A., van den Bogaard, P., Rifkin, S. A., van Oudenaarden, A. and Tyagi, S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat. Methods 5, 877-879 (2008).
36. Hacisuleyman, E. et al. Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre. Nat. Struct. Mol. Biol. 21, 198-206 (2014).
37. Dunagin, M., Cabili, M. N., Rinn, J. and Raj, A. Visualization of lncRNA by single-molecule fluorescence in situ hybridization. Methods Mol. Biol. 1262, 3-19 (2015).
38. Cabili, M. N. et al. Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol. 16, 20 (2015).
39. Loewer, S. et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nature Genet. 42, 1113-1117 (2010).
40. Wang, Y. et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev. Cell 25, 69-80 (2013).
41. Sun, T. et al. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. Oncogene 33, 2790-2800 (2014).
42. Flicek, P. et al. Ensembl 2012. Nucleic Acids Res. 40, D84-D90 (2012).
43. Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignmentfree logistic regression model. Nucleic Acids Res. 41, e74 (2013).
44. Lewis, B. P., Burge, C. B. and Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
45. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558 (2013).